AlzeCure Pharma logo

Loading..
Svenska
Svenska
  • News
    News
      • Upcoming events
      • Subscribe
  • About us
    About us
      • AlzeCure Pharma in brief
      • Mission, vision & strategy
      • A word from the CEO
      • Organization
        • Management team
        • Board of directors
        • Founders
        • Scientific advisors
        • Collaborations and Partnership
      • History
      • Career
        • Open positions
  • Research & development
    Research & development
      • Project portfolio
      • NeuroRestore
      • Alzstatin
      • Alzheimer’s disease
      • Depression
      • Painless
        • ACD440
        • TrkA-NAM
      • Pain
      • Small molecules
      • Publications
      • The patients story
  • Governance
    Governance
      • Corporate Governance Reports
      • General meeting
        • General meetings
      • Nomination Committee
      • Board of directors
      • Management team
      • Remuneration
      • Auditors
      • Articles of association
  • Investors
    Investors
      • Share Issue 2024
      • Capital Markets Day 2023
      • AlzeCure Pharma on First North Premier Growth Market
        • Certified Adviser
      • Prospectuses
        • Share Issue 2024
        • Rights Issue December 2022
        • Rights Issue 2022
        • Listing prospectus 2018
      • The share
        • Trading information
        • Sharecapital development
        • Dividend policy
        • Ownership structure
        • Insiders
        • Analyst Coverage
      • Financial reports
      • Financial calendar
      • Presentations and Interviews
      • Press releases
      • Subscribe
      • Contact
  • Media
    Media
      • Press releases
      • Presentations and Interviews
      • Video gallery
      • Image bank
        • Board of directors
        • Management
        • Founders
        • Logotype
      • Financial calendar
      • Subscribe
      • Contact
  • Subscribe
  • Contact
    Contact
      • Office
      • Investors
      • Media

Financial reports

All years
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
May 5, 2025

AlzeCure publishes its interim report for January – March 2025

April 3, 2025

AlzeCure Pharma publishes its Annual Report for 2024

February 27, 2025

AlzeCure publishes its Year-end report for January – December 2024

November 11, 2024

AlzeCure publishes its interim report for January – September 2024

August 26, 2024

AlzeCure publishes its interim report for January – June 2024

April 25, 2024

AlzeCure publishes its interim report for January – March 2024

April 4, 2024

AlzeCure Pharma publishes its Annual Report for 2023

February 27, 2024

AlzeCure publishes its Year-end report for January – December 2023

November 9, 2023

AlzeCure publishes its interim report for January – September 2023

August 24, 2023

AlzeCure publishes its interim report for January – June 2023

May 4, 2023

AlzeCure publishes its interim report for January – March 2023

April 5, 2023

AlzeCure Pharma publishes its Annual Report for 2022

February 24, 2023

AlzeCure publishes its Year-end report for January – December 2022

November 10, 2022

AlzeCure publishes its interim report for January – September 2022

August 25, 2022

AlzeCure publishes its interim report for January – June 2022

May 5, 2022

AlzeCure publishes its interim report for January – March 2022

April 6, 2022

AlzeCure Pharma publishes its Annual Report for 2021

February 24, 2022

AlzeCure publishes its Year-end report for 2021

November 10, 2021

AlzeCure publishes its interim report for January – September 2021

August 25, 2021

AlzeCure publishes its interim report for January – June 2021

May 5, 2021

AlzeCure publishes its interim report for January – March 2021

April 6, 2021

AlzeCure Pharma publishes its Annual Report for 2020

February 26, 2021

AlzeCure publishes its Year-end report for 2020

November 17, 2020

AlzeCure publishes its interim report for January – September 2020

August 25, 2020

AlzeCure publishes its interim report for January – June 2020

May 5, 2020

AlzeCure publishes its interim report for Q1 2020

April 15, 2020

AlzeCure Pharma publishes its Annual Report for 2019

February 28, 2020

AlzeCure publishes its Year-end Report for 2019

November 15, 2019

AlzeCure publishes its interim report for January – September 2019

August 22, 2019

AlzeCure publishes its interim report for January – June 2019

April 29, 2019

AlzeCure publishes its interim report for Q1 2019

April 15, 2019

AlzeCure publishes its Annual Report for 2018

February 28, 2019

AlzeCure publishes year-end report, January – December 2018

October 8, 2018

Interim Report July – September 2018

February 19, 2018

Annual Report 2017

  • Investors
    • Share Issue 2024
    • Capital Markets Day 2023
    • AlzeCure Pharma on First North Premier Growth Market
      • Certified Adviser
    • Prospectuses
      • Share Issue 2024
      • Rights Issue December 2022
      • Rights Issue 2022
      • Listing prospectus 2018
    • The share
      • Trading information
      • Sharecapital development
      • Dividend policy
      • Ownership structure
      • Insiders
      • Analyst Coverage
    • Financial reports
    • Financial calendar
    • Presentations and Interviews
    • Press releases
    • Subscribe
    • Contact
About us
  • AlzeCure Pharma in brief
  • Mission, Vision & Strategy
  • A word from the CEO
  • Organization
  • Career
  • History
Research & development
  • Project portfolio
  • NeuroRestore
  • Alzstatin
  • Alzheimer’s disease
  • Depression
  • Painless
  • Pain
  • Small molecules
  • Publications
  • The patients story
Governance
  • Corporate Governance Reports
  • General meeting
  • Nomination Committee
  • Board of directors
  • Management team
  • Remuneration
  • Auditors
  • Articles of association
Investors
  • Share Issue 2024
  • Capital Markets Day 2023
  • AlzeCure Pharma on First North Premier Growth Market
  • Prospectuses
  • The share
  • Financial reports
  • Financial calendar
  • Presentations and Interviews
  • Press releases
  • Subscribe
  • Contact
Media
  • Press releases
  • Presentations and Interviews
  • Video gallery
  • Image bank
  • Financial calendar
  • Subscribe
  • Contact
Contact
  • Office
  • Investors
  • Media

AlzeCure Pharma AB, Hälsovägen 7,  SE-141 57 Huddinge, Sweden. Registration number: 559094-8302.

  • Follow us on LinkedIn
  • About cookies
  • Privacy policy for Alzecure Pharma